Suppr超能文献

起源于右心室流出道的室性早搏的射频导管消融术。

Radiofrequency catheter ablation of premature ventricular contractions originating in the right ventricular outflow tract.

作者信息

Darrieux Francisco C C, Scanavacca Maurício I, Hachul Denise T, Melo Sissy L, D'Avilla André B, Gruppi César J, Moffa Paulo J, Sosa Eduardo A

机构信息

Instituto do Coração, Hospital das Clínicas, FM, USP, São Paulo, SP, Brazil.

出版信息

Arq Bras Cardiol. 2007 Mar;88(3):265-72. doi: 10.1590/s0066-782x2007000300003.

Abstract

OBJECTIVES

To evaluate if radiofrequency catheter ablation is an effective procedure for the treatment of right ventricular outflow tract premature ventricular contractions (RVOT-PVC) and ascertain if it results in an improvement of symptoms.

METHODS

A prospective study with 30 consecutive patients (mean age 40 +/- 13 years, 25 females), with no apparent structural cardiopathy, with very frequent (mean density of 1,263 +/- 593/h) RVOT-PVC, symptomatic for more than one year (mean = 74 months) and resistant to antiarrhythmic drugs (3 +/- 1.7, including beta-blockers), who underwent radiofrequency catheter ablation.

RESULTS

After the first procedure, there were 23 initial successful cases (76.6%) and 7 initial failures (23.4%). Four patients experienced relapses, two of whom did not undergo the second procedure. The second procedure was carried out in 9 patients (7 initial failures and 2 relapses), and there was success in 5 additional patients, one of them by epicardial access. The final success rate was 80% (24/30), and there were no major complications. After a mean follow-up of 14 +/- 6 months, in the successful group there was a reduction greater than 90% in density of premature ventricular contractions (PVC) (24/24; p<0.0001) and a resulting absence of symptoms in the majority of patients (23/24; p<0.001).

CONCLUSION

Radiofrequency catheter ablation is a safe and effective treatment for patients with persistent and symptomatic PVC with RVOT morphology.

摘要

目的

评估射频导管消融术是否是治疗右心室流出道室性早搏(RVOT - PVC)的有效方法,并确定其是否能改善症状。

方法

一项前瞻性研究,纳入30例连续患者(平均年龄40±13岁,25例女性),无明显结构性心脏病,RVOT - PVC非常频繁(平均频率为1263±593次/小时),有症状超过一年(平均74个月)且对抗心律失常药物耐药(3±1.7种,包括β受体阻滞剂),接受射频导管消融术。

结果

首次手术后,有23例初始成功病例(76.6%)和7例初始失败病例(23.4%)。4例患者复发,其中2例未接受第二次手术。9例患者(7例初始失败和2例复发)接受了第二次手术,另外5例患者成功,其中1例通过心外膜途径。最终成功率为80%(24/30),无重大并发症。平均随访14±6个月后,成功组室性早搏(PVC)频率降低超过90%(24/24;p<0.0001),大多数患者无症状(23/24;p<0.001)。

结论

射频导管消融术是治疗持续性且有症状的RVOT形态PVC患者的一种安全有效的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验